報價延遲最少15分鐘:2026/02/15 13:11 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
12.4 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.16/1.00
|
|
企業價值
72.70M
|
| 資產負債 |
|
每股賬面淨值
6.11
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
2.13M
|
|
每股收益
0.89
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. |
